1-(4-브로모펜일)피페라진

1-(4-Bromophenyl)piperazine

HCID 2735629

기본 정보

CAS
66698-28-0
표준 SMILES
Brc1ccc(N2CCNCC2)cc1
InChIKey
PJHPFAFEJNBIDC-UHFFFAOYSA-N
분자식
C10H13BrN2
평균 분자량
241.13 g/mol
단동위원소 질량
240.02621052

이름 및 식별자

우선 이름
1-(4-Bromophenyl)piperazine
IUPAC
1-(4-bromophenyl)piperazine
현지명
1-(4-브로모펜일)피페라진
영어명
1-(4-Bromophenyl)piperazine
분자식
C10H13BrN2
분자량
241.13

이름 및 동의어

1-(4-bromophenyl)piperazine66698-28-0Piperazine, 1-(4-bromophenyl)-4-BppRX2Y9C2G6XN-(4-Bromophenyl)piperazine1-(Para-bromophenyl)piperazineDTXSID50370841RefChem:74431DTXCID70321875663-248-4MFCD00130198
이름 더 보기
1-(4-브로모펜일)피페라진KML-30CML-0271-(4-Bromophenyl)1-(4-Bromophenyl)piperazine - [B93256]1-(4-BROMO-PHENYL)-PIPERAZINE DIHYDROCHLORIDE
PBPP1-(4-bromophenyl)-piperazine4-bromophenylpiperazineUNII-RX2Y9C2G6X4-(4-bromophenyl)piperazineOprea1_814607SCHEMBL15942SCHEMBL3183333

데이터베이스 식별자

CAS
66698-28-0
PubChem CID
2735629
DTXSID
DTXSID50370841
UNII
RX2Y9C2G6X
EC Number
663-248-4
Nikkaji
J1.509.774D

물성

구조 계산 물성

XLogP
1.9
극성 표면적
15.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
2
회전 가능 결합 수
1
무거운 원자 수
13

물리화학적 성질

녹는점
91 · 91-95 °C
끓는 점
353.3 · 353.3±27.0 °C(Predicted)
밀도
1.386 · 1.386±0.06 g/cm3(Predicted)
저장 조건
2 · 2-8°C
물리적 상태
solid
산도 계수 (pKa)
8.88 · 8.88±0.10(Predicted)

안전 및 규제

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%)

안전 데이터

wgk
1
risk_code
20/21/22
hazard_code
Xi,Xn
위험 참고 사항
Irritant
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 Oral
스토리지 클래스
11 - Combustible Solids

화학 및 산업

응용 분야 · 1건

개요1-(4-Bromophenyl)piperazine (street names: 4-bromo-piperein, 4-BP, brein) is structurally related to 1-(4-fluorophenyl)piperazine and to 1-(4-chlorophenyl)piperazine. The only difference is the halogen substituent type attached to the phenyl ring's para-position. In the case of NPSs from the methcathinone group, which are also neurotransmitter releasers, structure–activity studies demonstrated that the replacement of a fluorine or chlorine atom with a bromine atom resulted in a compound with more potency for the release of both dopamine and serotonin. The lowest dopamine selectivity, an additional consequence of these halogen replacements, results in lower abuse potential in favor of empathogenic properties[1].

공급사100 곳

河北凡博医药科技有限公司15588346797
天津始加生物医药科技有限公司15022261580 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
安徽合诺生物科技有限公司0555-2761852

관련 반응

53건

화합물 노트

불러오는 중…